The Epilepsy Therapy Project Board of Directors brings together scientific, business and community leaders dedicated to building the resources and capabilities of our organization to better pursue our mission of advancing new therapies for epilepsy.

• Warren Lammert: Chairman & Co-Founder; Founder, Granite Point Capital
• Karen L. Bergman: Founder and Principal, BCC Partners
• Joyce Cramer: President; Associate Research Scientist, Yale University School of Medicine
• Orrin Devinsky, M.D.: Co-Founder; Vice President for Translational Programs; Scientific Advisory Board; Professor of Neurology, Neurosurgery and Psychiatry and Director, NYU Comprehensive Epilepsy Center, New York University
• Frank Fischer: President & CEO, NeuroPace, Inc.
• Jacqueline French, M.D.: Vice President for Clinical Research; Chair, Scientific Advisory Board; Professor of Neurology, NYU Comprehensive Epilepsy Center, New York University; Director of the Epilepsy Study Consortium
• May Liang: General Counsel and Senior Vice President, Ruckus Network, Inc.
• Kevin Malone: President and Founder, Greenrock Research
• Garry E. Menzel, Ph.D.: Chair, Business Advisory Board, Executive Vice President Corporate Development and Finance, Regulus Therapeutics
• David A. Sadock: President & CEO, Ethos Health Communications
• Nancy Santilli, B.S.N., M.S.N.: VP Commercial Strategy and Portfoloio Planning, Endo Pharmaceuticals, Inc.
• Howard Soule, Ph.D.:  Executive Vice President and Chief Science Officer, Prostate Cancer Foundation; Senior Fellow, Milken Institute
• Linda Warner: Relocation Specialist, Coldwell Banker Burnet
• Kim Macher: (ex officio) Executive Director, Epilepsy Therapy Project

Continue to: Scientific Advisory Board